Companion Society Meetings
North American Society of Head and Neck Pathology
A Modernized Approach to Neuroendocrine Tumors of the Head and Neck
Sunday, March 18, 2018, 1:30 - 5:00 PM
3 CME and 3 SAMs
Michelle D. Williams, M.D., MD Anderson Cancer Center, Houston, TX James S. Lewis, M.D., Vanderbilt University Medical Center, Nashville, TN
There is significant diversity of neuroendocrine tumors arising in the head and neck region, especially regarding their clinical behavior. Each presenter brings insight into the specific pathologic challenges in diagnosis and importantly the differential diagnosis and pathology factors important for patient care in each entity and anatomic area covered. Additionally, advances that have occurred in each area will be presented.
Upon completion of this educational activity, the learner will be able to:
- Define the spectrum of neuroendocrine entities that develop in the various subsites within the head and neck
- Consider neuroendocrine tumors in the differential diagnosis based on subsites within head and neck and apply immunohistochemical tools for their diagnosis
- Recognize evolving molecular and pathogenic factors that may contribute to neuroendocrine neoplasm in the head and neck
Michelle D. Williams, M.D., MD Anderson Cancer Center, Houston, TX
|1:35 PM||Grading Head and Neck Neuroendocrine Carcinomas, and Laryngeal Neuroendocrine Carcinomas
Bayardo Perez-Ordonez, MD, University of Toronto, Toronto, ON, Canada
|2:00 PM||HPV- related Neuroendocrine Carcinomas
Williams H. Westra, MD, John Hopkins University, Baltimore, MD
|2:25 PM||Salivary Neuroendocrine Carcinomas - An Overview of a Rare Disease with an Emphasis on Determining Tumor Origin
Rebecca D. Chernock, MD, Washington University, St. Louis, MO
|2:50 PM||Middle Ear Adenoma
Lester Thompson, MD, Woodland Hills Medical Center, Woodland Hills, CA
|3:30 PM||Sinonasal Neuroendocrine Tumors
Diana Bell, MD, MD Anderson Cancer Center, Houston, TX
|4:00 PM||Merkel Cell Carcinoma
Michael T. Tetzlaff, MD, PhD, MD Anderson Cancer Center, Houston, TX
Continuing Medical Education and Maintenance of Certification
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and North American Society of Head and Neck Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of
3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 3 SAM credit hours.